Progress in the treatment and outcome of pediatric inflammatory bowel disease patients

Kaija Leena Kolho*, Antti Ainamo

*Corresponding author for this work

Research output: Contribution to journalReview Articlepeer-review

7 Citations (Scopus)


Introduction: The number of pediatric patients with inflammatory bowel disease (IBD), namely Crohn´s disease, ulcerative colitis and unclassified colitis, has rapidly increased in Western countries. Areas covered: This review discusses how the treatment of pediatric IBD patients has improved,with attention given to therapeutic quality and cost. The literature search covers Medline-PubMed and the Cochrane Library, with February 2016 as the last search dates. Similarly to what has been the trend in the management of adult IBD, pediatric IBD therapy has become more active than before. High use of immunosuppressants and the availability of biological therapeutic agents has helped to control the extensive and aggressive course of pediatric IBD. Full disease control at an early phase has advantages such as preserving normal child growth and development, maintaining overall good health and quality of life, as well as decreasing the psychosocial burden of the disease. Expert commentary: A key research direction is to tailor treatment modalities according to anticipated individual phenotype and disease course. Another is to reduce healthcare costs by decreasing the so-far high rate of surgery of pediatric IBD patients, and, instead, to develop a more active approach to treatment than before.

Original languageEnglish
Pages (from-to)1337-1345
Number of pages9
Issue number12
Publication statusPublished - 1 Dec 2016
MoE publication typeA2 Review article in a scientific journal


  • Calprotectin
  • children
  • colitis ulcerative
  • cost of care
  • Crohn´s disease
  • fecal markers
  • growth
  • management


Dive into the research topics of 'Progress in the treatment and outcome of pediatric inflammatory bowel disease patients'. Together they form a unique fingerprint.

Cite this